HLB innoVation to Conduct NDR for Overseas Institutional Investors Focusing on Subsidiary Verismo Therapeutics to Enhance Corporate Value
HLB innoVation announced it will hold a Non-Deal Roadshow NDR for major overseas institutional investors in Hong Kong and Singapore from July 9 to 15, 2026.
The purpose of this IR event is to enhance corporate understanding and value, with a focus on explaining the business of its subsidiary Verismo Therapeutics and Q&A sessions.
The event is sponsored by Jefferies Securities Seoul Branch, leveraging the credibility of a global investment bank.
This is a routine investor relations activity without any capital raising or changes in share structure, thus not directly impacting existing shareholder value.
[AI Summary]This NDR by HLB innoVation is a marketing-focused event to present the value of its subsidiary Verismo Therapeutics to foreign institutional investors. With no capital changes or dividend adjustments, the immediate stock price impact is limited, but it may enhance corporate recognition over the long term. The backing by a reputable global sponsor keeps governance risk low.